BLACK DIAMOND THERAPEUTICS INC. - COMMON STOCK

Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

06 ноя 2023 07:45:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535

14 окт 2023 12:30:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

04 окт 2023 12:14:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces CEO Transition

18 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer

11 сен 2023 08:00:01 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

05 сен 2023 08:00:01 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

11 авг 2023 07:30:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock

29 июн 2023 20:57:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock

28 июн 2023 16:23:52 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families

27 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer

13 июн 2023 08:00:01 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference

02 июн 2023 08:00:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

09 май 2023 07:30:01 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Days

18 апр 2023 08:00:01 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535 and Preclinical Data on BDTX-1535 and BDTX-4933 at the 2023 American Association of Cancer Research Annual Meeting

17 апр 2023 16:01:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

09 мар 2023 07:30:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference

27 фев 2023 08:00:01 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

05 янв 2023 08:00:02 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Changes to Board of Directors

19 дек 2022 08:00:00 Источник Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company

12 дек 2022 08:00:01 Источник Nasdaq GlobeNewswire